Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1004
-
Total 13F shares, excl. options
-
187M
-
Shares change
-
+1.27M
-
Total reported value, excl. options
-
$58.6B
-
Value change
-
+$470M
-
Put/Call ratio
-
1.15
-
Number of buys
-
460
-
Number of sells
-
-416
-
Price
-
$313.12
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q3 2017
1,138 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q3 2017.
BIOGEN INC. - Common Stock (BIIB) has 1,004 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 187M shares
.
Largest 10 shareholders include BlackRock Inc. (16.9M shares), PRIMECAP MANAGEMENT CO/CA/ (15.2M shares), VANGUARD GROUP INC (14.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.7M shares), STATE STREET CORP (9.67M shares), Clearbridge Investments, LLC (9.25M shares), FMR LLC (7.15M shares), WELLINGTON MANAGEMENT GROUP LLP (5.17M shares), Invesco Ltd. (3.38M shares), and NORTHERN TRUST CORP (3.03M shares).
This table shows the top 1004 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.